Literature DB >> 26251963

Analysis of the advantage features of Beijing surveillance network for Creutzfeldt-Jakob disease.

Qi Shi1, Xiu-Chun Zhang, Wei Zhou, Kang Xiao, Cao Chen, Hai-Yan Zhang, Jing-Yi Sun, Li-Na Chen, Xiao-Mei Zhang, Jun Han, Xiao-Ping Dong.   

Abstract

Since 2006, China has conducted the surveillance program for Creutzfeldt-Jakob disease (CJD) and other subtypes of prion diseases covering 12 provinces. In this study, the characteristics and special role of Beijing CJD surveillance network in the national CJD surveillance system were analyzed. Based on the registered permanent resident places, all reporting suspected CJD cases and diagnosed CJD cases via Beijing CJD surveillance network between 2006 and 2013 were grouped as the cases from Beijing and from outside of Beijing. Both numbers of the suspected and diagnosed CJD cases via Beijing CJD surveillance network constantly increased along with the years, totally 532 reporting cases and 192 diagnosed CJD cases were obtained in the past 8 y. About 75% of suspected and diagnosed CJD cases via Beijing CJD surveillance network came from other provinces, mainly from neighboring provinces. Altogether, 46 different hospitals in the Beijing region have reported suspected CJD cases to the CJD surveillance system during the period from 2006 to 2013. Five hospitals continually reported suspected CJD cases during those 8 y and 5 other hospitals had reported cases except for 1 to 2 y. Additionally, we found that the diagnosed CJD patients from Beijing region had less numbers of hospital transfer and shorter interval from the disease onset to the final diagnosis than those outside of Beijing. It indicates that as the most important component, Beijing CJD surveillance network functions more actively, which supplies the special medical services not only for Beijing residents but also for patients from all of China.

Entities:  

Keywords:  Beijing; CJD; China; network; surveillance

Mesh:

Year:  2015        PMID: 26251963      PMCID: PMC4601330          DOI: 10.1080/19336896.2015.1075115

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  17 in total

Review 1.  Neuropathology of prion diseases.

Authors:  Herbert Budka
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

2.  Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease.

Authors:  Katsuya Satoh; Minoru Tobiume; Yuki Matsui; Kazuo Mutsukura; Noriyuki Nishida; Yusei Shiga; Katsumi Eguhchi; Susumu Shirabe; Testutaro Sata
Journal:  Lab Invest       Date:  2010-08-09       Impact factor: 5.662

3.  First symptom and initial diagnosis in sporadic CJD patients in Germany.

Authors:  Anna Krasnianski; Judith Kaune; Klaus Jung; Hans A Kretzschmar; Inga Zerr
Journal:  J Neurol       Date:  2014-07-15       Impact factor: 4.849

Review 4.  Prions and prion-like proteins.

Authors:  Paul E Fraser
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

Review 5.  Historical overview of prion diseases: a view from afar.

Authors:  Pawel P Liberski
Journal:  Folia Neuropathol       Date:  2012       Impact factor: 2.038

Review 6.  Therapies for human prion diseases.

Authors:  Peter K Panegyres; Elizabeth Armari
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

Review 7.  Prion diseases.

Authors:  Leonel T Takada; Michael D Geschwind
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

Review 8.  Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease.

Authors:  Y Shiga; K Miyazawa; S Sato; R Fukushima; S Shibuya; Y Sato; H Konno; K Doh-ura; S Mugikura; H Tamura; S Higano; S Takahashi; Y Itoyama
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

Review 9.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Analyses of the survival time and the influencing factors of chinese patients with prion diseases based on the surveillance data from 2008-2011.

Authors:  Cao Chen; Ji-Chun Wang; Qi Shi; Wei Zhou; Xiao-Mei Zhang; Jin Zhang; Chan Tian; Chen Gao; Xiao-Ping Dong
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

View more
  7 in total

1.  Clinical and laboratory features of 14 young Chinese probable sCJD patients.

Authors:  Qi Shi; Kang Xiao; Cao Chen; Wei Zhou; Chen Gao; Jing Wang; Bao-Yun Zhang; Yuan Wang; Xiao-Ping Dong
Journal:  Prion       Date:  2017-03-09       Impact factor: 3.931

2.  Difference of geographic distributions of the Chinese patients with prion diseases in the permanent resident places and referring places.

Authors:  Kang Xiao; Ming-Fan Pang; Yue-Qiao Zhao; Li-Ping Gao; Yue-Zhang Wu; Yuan Wang; Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2022-12       Impact factor: 2.547

3.  Quality evaluation for the surveillance system of human prion diseases in China based on the data from 2010 to 2016.

Authors:  Qi Shi; Wei Zhou; Cao Chen; Chen Gao; Kang Xiao; Jing Wang; Bao-Yun Zhang; Yuan Wang; Feng Zhang; Xiao-Ping Dong
Journal:  Prion       Date:  2016-11       Impact factor: 3.931

Review 4.  The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.

Authors:  Neil Watson; Jean-Philippe Brandel; Alison Green; Peter Hermann; Anna Ladogana; Terri Lindsay; Janet Mackenzie; Maurizio Pocchiari; Colin Smith; Inga Zerr; Suvankar Pal
Journal:  Nat Rev Neurol       Date:  2021-05-10       Impact factor: 42.937

5.  The Features of Genetic Prion Diseases Based on Chinese Surveillance Program.

Authors:  Qi Shi; Wei Zhou; Cao Chen; Bao-Yun Zhang; Kang Xiao; Xiu-Chun Zhang; Xiao-Jing Shen; Qing Li; Li-Quan Deng; Jian-Hua Dong; Wen-Qing Lin; Pu Huang; Wei-Jia Jiang; Jie Lv; Jun Han; Xiao-Ping Dong
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

6.  Characteristics of Chinese patients with genetic CJD who have E196A or E196K mutation in PRNP: comparative analysis of patients identified in the Chinese National CJD Surveillance System.

Authors:  Qi Shi; Kang Xiao; Cao Chen; Wei Zhou; Li-Ping Gao; Yue-Zhang Wu; Yuan Wang; Chao Hu; Chen Gao; Xiao-Ping Dong
Journal:  BMJ Open       Date:  2021-11-15       Impact factor: 2.692

Review 7.  Epidemiological characteristics of human prion diseases.

Authors:  Cao Chen; Xiao-Ping Dong
Journal:  Infect Dis Poverty       Date:  2016-06-02       Impact factor: 4.520

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.